Gardasil's use in men intensifies vaccine debate

03/27/2009 | Washington Post (tiered subscription model), The

The debate over whether cervical cancer vaccine Gardasil will cause an increase in sexual activity among teenage girls has shifted to whether the vaccine is safe and cost-effective in protecting boys against genital warts and other cancers that can be triggered by human papillomavirus. The change in discussion comes as Merck & Co. awaits FDA approval to promote the use of Gardasil in males ages 9 to 26.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX